Guardant Health, Novavax And Some Other Big Stocks Moving Lower In Today's Pre-Market Session


U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session.

  • Guardant Health, Inc. GH dropped 33.1% to $27.59 in pre-market trading after the company announced results from its ECLIPSE study evaluating the performance of its blood test for detecting colorectal cancer.
  • MorphoSys AG MOR shares declined 19.8% to $3.20 in pre-market trading. MorphoSys subsidiary Constellation Pharmaceuticals recently entered into a global licensing agreement with Novartis to research, develop and commercialize its pre-clinical inhibitors of a novel cancer target.
  • Bionano Genomics, Inc. BNGO dropped 10.4% to $1.73 in pre-market trading after dropping around 7% on Thursday.
  • Arcos Dorados Holdings Inc. ARCO fell 7.2% to $7.01 in pre-market trading. Arcos Dorados Holdings, last month, reported third-quarter FY22 sales growth of 27% year-on-year to $921.7 million, beating the consensus of $902.19 million.
  • Qurate Retail, Inc QRTEA shares dropped 6.3% to $1.80 in pre-market trading after dropping 9% on Thursday.
  • 23andMe Holding Co. ME fell 6% to $2.53 in pre-market trading.
  • Novavax, Inc. NVAX fell 4.6% to $10.80 in pre-market trading. Novavax said it has priced its underwritten public offering to sell 6.5 million shares of its common stock at $10 per share.

Also check out this CNN Fear & Greed Index Moves To 'Neutral' Zone After Dow Tumbles Over 700 Points .
Don’t forget to check out our premarket coverage here .

Market News and Data brought to you by Benzinga APIs
Posted In: NewsPenny StocksSmall CapPre-Market OutlookMarketsMoversTrading Ideasbig losersTop Losers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!